GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM.PR.A.PFD) » Definitions » Total Liabilities

Big Pharma Split (TSX:PRM.PR.A.PFD) Total Liabilities : C$10.68 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split Total Liabilities?

Big Pharma Split's Total Liabilities for the quarter that ended in Dec. 2023 was C$10.68 Mil.

Big Pharma Split's quarterly Total Liabilities declined from Dec. 2022 (C$19.37 Mil) to Jun. 2023 (C$10.37 Mil) but then increased from Jun. 2023 (C$10.37 Mil) to Dec. 2023 (C$10.68 Mil).

Big Pharma Split's annual Total Liabilities increased from Dec. 2021 (C$15.41 Mil) to Dec. 2022 (C$19.37 Mil) but then declined from Dec. 2022 (C$19.37 Mil) to Dec. 2023 (C$10.68 Mil).

Big Pharma Split Total Liabilities Historical Data

The historical data trend for Big Pharma Split's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split Total Liabilities Chart

Big Pharma Split Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial 10.87 9.75 15.41 19.37 10.68

Big Pharma Split Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.41 15.88 19.37 10.37 10.68

Big Pharma Split Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Big Pharma Split's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=26.535-15.851
=10.68

Big Pharma Split's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=26.535-15.851
=10.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Big Pharma Split Total Liabilities Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Big Pharma Split (TSX:PRM.PR.A.PFD) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM.PR.A.PFD) » Definitions » Total Liabilities
Comparable Companies
TSX:PWI TSXV:MONT TSX:XTD TSX:MDS.UN TSXV:FW TSXV:TORR TSX:MSRE.UN XCNQ:IDK TSXV:TIE XCNQ:SPLY BLK BX OSTO:INVE A TSX:BN KKR APO BK AMP XSWX:PGHN LSE:III
Traded in Other Exchanges
PRM:Canada
Address
610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Website
https://www.harvestportfolios.com
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.

Big Pharma Split (TSX:PRM.PR.A.PFD) Headlines

No Headlines